Copyright
©The Author(s) 2022.
World J Hepatol. Mar 27, 2022; 14(3): 551-558
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.551
Published online Mar 27, 2022. doi: 10.4254/wjh.v14.i3.551
Parameter | Odds ratio | 95%CI | P value |
Age (18-65) | 1.658 | 1.524-1.804 | < 0.0001 |
Male | 1.008 | 0.934-1.088 | 0.841 |
Caucasian | 1.636 | 1.489-1.799 | < 0.0001 |
Obesity | 3.616 | 3.318-3.940 | < 0.0001 |
T2DM | 2.178 | 1.994-2.379 | < 0.0001 |
Dyslipidemia | 2.346 | 2.121-2.596 | < 0.0001 |
Hypertension | 1.326 | 1.201-1.465 | < 0.0001 |
Metabolic syndrome | 4.782 | 4.782-5.460 | < 0.0001 |
Hypothyroidism | 1.587 | 1.388-1.815 | < 0.0001 |
Hypothyroidism on Thyroxine replacement therapy | 1.106 | 0.952-1.285 | 0.188 |
- Citation: Almomani A, Hitawala AA, Kumar P, Alqaisi S, Alshaikh D, Alkhayyat M, Asaad I. Prevalence of hypothyroidism and effect of thyroid hormone replacement therapy in patients with non-alcoholic fatty liver disease: A population-based study. World J Hepatol 2022; 14(3): 551-558
- URL: https://www.wjgnet.com/1948-5182/full/v14/i3/551.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i3.551